Key Financial Inc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22
Closed -$2.23K 1411
2025
Q4
$2.23K Hold
22
﹤0.01% 1158
2025
Q3
$1.24K Sell
22
-1
-4% -$50 ﹤0.01% 1245
2025
Q2
$1.22K Hold
23
﹤0.01% 1250
2025
Q1
$996 Hold
23
﹤0.01% 1231
2024
Q4
$1.29K Hold
23
﹤0.01% 1199
2024
Q3
$1.57K Buy
23
+5
+28% +$282 ﹤0.01% 1138
2024
Q2
$760 Hold
18
﹤0.01% 1210
2024
Q1
$1.24K Hold
18
﹤0.01% 1155
2023
Q4
$1.33K Hold
18
﹤0.01% 1147
2023
Q3
$1.23K Hold
18
﹤0.01% 1165
2023
Q2
$1.69K Hold
18
﹤0.01% 1187
2023
Q1
$1.22K Hold
18
﹤0.01% 1009
2022
Q4
$585 Hold
18
﹤0.01% 1085
2022
Q3
$1K Hold
18
﹤0.01% 1022
2022
Q2
$1K Hold
18
﹤0.01% 1010
2022
Q1
$1K Hold
18
﹤0.01% 999
2021
Q4
$1K Hold
18
﹤0.01% 885
2021
Q3
$2K Buy
+18
New +$1.9K ﹤0.01% 800

Other funds holding EXAS

Key Financial Inc's EXAS Position: Q1 2026 in Review

Key Financial Inc sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 22 shares — an estimated $2.23K sold.

Key Financial Inc first reported a position in EXAS in Q3 2021 and held it in 18 quarters. The position peaked at $2.23K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Key Financial Inc reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Key Financial Inc sold 22 Exact Sciences shares in Q1 2026, an estimated $2.23K.
  • Key Financial Inc first reported a position in Exact Sciences in Q3 2021 and held it in 18 quarters.
  • Key Financial Inc's Exact Sciences position peaked at $2.23K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.